Molecular Imaging: Page 43

PET strengthens case for cause of schizophrenia

By Wayne Forrest

By combining PET imaging with a radiotracer that binds to a specific protein, U.K. researchers may have validated the belief that dysfunctional neuronal connections in the brain are the underlying cause of schizophrenia, according to a study published on 14 January in Nature Communications.

January 16, 2020

Report: Fujifilm makes pitch for Curium Pharma

By Wayne Forrest

In what would be its latest deal in an ongoing acquisition spree in healthcare, Fujifilm has made an offer to buy French radiopharmaceutical developer Curium Pharma in a transaction that could be valued as high as 2.7 billion euros, according to a 14 January report from Bloomberg.

January 15, 2020

LMI highlights research on PET neuroimaging tracers

By AuntMinnieEurope.com staff writers

Berlin-based Life Molecular Imaging (LMI) is unveiling new study findings on its PET neuroimaging tracers through nine different presentations at this week's Human Amyloid Imaging meeting in Miami, Florida, U.S.

January 15, 2020

Dutch refine use of PET to predict cancer therapy outcome

By Wayne Forrest

Researchers from the Netherlands are edging closer to proving the value of zirconium-89 immuno-PET as a noninvasive approach to predicting the effectiveness of therapy for cancerous tumors. Their findings have appeared in the December edition of the Journal of Nuclear Medicine.

December 19, 2019

Affidea, Subtle Medical partner for PET/CT

By AuntMinnieEurope.com staff writers

Diagnostic imaging, outpatient, and cancer care services provider Affidea and imaging artificial intelligence software developer Subtle Medical have formed a strategic partnership to improve the patient experience during PET/CT scans.

December 16, 2019

PET/MRI wins support in breast lesion comparisons

By Wayne Forrest

Researchers from the University of Düsseldorf in Germany have found that the combination of PET with MRI was statistically superior to MRI alone for normal detection and staging of breast cancer, as well as in the detection of distant metastases (M staging). They revealed their findings at RSNA 2019.

December 15, 2019

AI-assisted FDG-PET/CT advances lung nodule detection

By Wayne Forrest

Swiss investigators have developed an artificial intelligence (AI) algorithm that could become a valuable tool for detecting small, FDG-avid pulmonary nodules on oncologic PET/CT scans, according to a study published online on 10 December in European Radiology.

December 15, 2019

German team shows value of FDG-PET/MRI in breast cancer

By Wayne Forrest

A new study from Düsseldorf, Germany, has found that FDG-PET/MRI shows promise for accurate staging of breast cancer, but the modality still isn't as accurate as sentinel lymph node biopsy. The researchers presented their results at RSNA 2019.

December 12, 2019

Is it safe to undergo FDG-PET/CT after cardiac surgery?

By Wayne Forrest

Determining when it's safe for patients to undergo FDG-PET/CT after aortic prosthetic heart valve implantation is a controversial topic. A Dutch study presented on Tuesday at RSNA 2019 found that such a scan within the first 12 months is viable.

December 4, 2019

CMR adds to Egyptian installed base

By AuntMinnieEurope.com staff writers

CMR Molecular Imaging, a subsidiary of PET developer Compañía Mexicana de Radiología (CMR) Naviscan, said it has installed its breast PET imaging system at Baheya Breast Cancer Center in Egypt.

November 26, 2019

MR Solutions brings 7T preclinical PET/MRI to Israel

By AuntMinnieEurope.com staff writers

Preclinical imaging technology developer MR Solutions has installed its 7-tesla PET/MRI preclinical scanner in Israel for the first time.

November 25, 2019

AuntMinnieEurope.com Molecular Imaging Insider

By Wayne Forrest

November 6, 2019

Previous Page

Page 43 of 121

Next Page